{"id":"W4400248956","doi":"10.1038/s44321-024-00094-2","title":"FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer","year":2024,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"Pershing Square Sohn Cancer Research Alliance; Memorial Sloan-Kettering Cancer Center; METAvivor; Irving Medical Center, Columbia University; National Cancer Institute; Emory University; Susan G. Komen; Monique Weill-Caulier Trust; Moffitt Cancer Center; American Cancer Society; Irma T. Hirschl Trust; U.S. Department of Defense","keywords":"Cancer research; Breast cancer; Medicine; Cancer; PARP inhibitor; Synthetic lethality; Biology; Internal medicine; DNA repair; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004072865,0.0002966149,0.0005202962,0.0005157091,0.00003034074,0.00001864076,0.0001460478,0.0001627072,0.001208736],"category_scores_gemma":[0.00006485507,0.0002497388,0.00007447044,0.001285044,0.0001595755,0.0001472005,0.00003268692,0.0005465079,0.0000232548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009241733,"about_ca_system_score_gemma":0.0004513969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001156722,"about_ca_topic_score_gemma":0.0005991283,"domain_scores_codex":[0.9976293,0.0001051565,0.0005683141,0.0006318457,0.0006271584,0.0004382286],"domain_scores_gemma":[0.9990764,0.0000842052,0.00008783856,0.0004762683,0.0001139552,0.0001612819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004488959,0.0001361331,0.002052762,0.0007209164,0.00007198582,0.0005554393,0.00160813,0.00005923483,0.9726489,0.0005236894,0.01682859,0.004345301],"study_design_scores_gemma":[0.009380452,0.0002841395,0.03824782,0.03261913,0.0001609317,0.00005967407,0.0003465022,0.0009934575,0.8708382,0.003176812,0.04314018,0.00075269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8343793,0.02544551,0.0007236064,0.1316797,0.001607218,0.00141164,0.0000614245,0.0002222525,0.004469331],"genre_scores_gemma":[0.9921064,0.001352366,0.0002941407,0.003523958,0.001005508,0.0005688838,0.00003725662,0.00008328899,0.001028221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1577271,"threshold_uncertainty_score":0.9999955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01591781675838453,"score_gpt":0.3242400664686054,"score_spread":0.3083222497102208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}